bezafibrate has been researched along with Necrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornelius, N; Gregersen, N; Olsen, RK | 1 |
| Fujita, T; Maeda, R; Negishi, K; Noiri, E; Portilla, D; Sugaya, T | 1 |
| Fernández-Solá, J; Fueyo, J; Gómez Manzano, C; Pedro-Botet Montoya, J | 1 |
1 review(s) available for bezafibrate and Necrosis
| Article | Year |
|---|---|
Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
Topics: Antioxidants; Apoptosis; Bezafibrate; Electron Transport Chain Complex Proteins; Fatty Acids; Genetic Variation; Genotype; Humans; Lipid Metabolism, Inborn Errors; Necrosis; Oxidative Stress; Phenotype; Protein Folding; Reactive Nitrogen Species; Reactive Oxygen Species | 2013 |
2 other study(ies) available for bezafibrate and Necrosis
| Article | Year |
|---|---|
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.
Topics: Animals; Apoptosis; Bezafibrate; Cisplatin; Cytoprotection; Fatty Acid-Binding Proteins; Kidney; Kidney Diseases; Lipid Peroxidation; Mice; Mice, Transgenic; Necrosis; PPAR alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
[Bezafibrate-induced necrotizing myopathy].
Topics: Bezafibrate; Biopsy; Female; Humans; Middle Aged; Muscles; Muscular Diseases; Necrosis | 1991 |